Down's syndrome testing hits several European markets

August 20, 2012

A new prenatal test for Down's syndrome hit the market in Germany and several other European countries Monday, the manufacturer said, amid a controversy over whether it could lead to more abortions.

The product, marketed as PrenaTest and manufactured by German life sciences company LifeCodexx, "is targeted exclusively toward women in their 12th week of pregnancy and beyond who are at an increased risk" of delivering a child with Down's syndrome, the company said in a statement.

The test which involves screening pregnant women's blood samples for the presence of foetal Down's syndrome -- also known as -- had recently come under fire from rights groups concerned about abortions.

In June, the international federation of Down's syndrome organisations objected to such testing at the .

The federation, grouping 30 associations in 16 countries, said the Strasbourg court should "recognise the human condition and protect the right to life of people with Down's syndrome and those handicapped".

But last month, Switzerland gave the test the green light with a decision by Swissmedic, the national agency for therapeutic products.

Germany's ombudsman for the disabled, Hubert Huppe, for his part called the test "illegal", fearing a "selection of man by Down's Syndrome", but it did not stop the test from going to market.

Down's syndrome is caused by having an extra copy of and the risk increases as a woman gets older.

LifeCodexx described their procedure as a "risk-free alternative to common invasive examination methods such as amniocentesis".

currently used for -- in the 16th week of pregnancy -- pose a one percent risk of foetal loss.The diagnosis is therefore only made available to high risk women, which fails to catch all cases.

Besides Germany and Switzerland, the test is also now available in Austria and Liechtenstein.

Explore further: Controversial Down's syndrome testing gets Swiss go-ahead

Related Stories

Blood test detects Down syndrome during pregnancy

February 23, 2012

(HealthDay) -- A second company reports that it has developed a prenatal blood test to detect Down syndrome, potentially providing yet another option for pregnant women who want to know whether their unborn child has the ...

Recommended for you

Zika virus infection alters human and viral RNA

October 20, 2016

Researchers at University of California San Diego School of Medicine have discovered that Zika virus infection leads to modifications of both viral and human genetic material. These modifications—chemical tags known as ...

Food-poisoning bacteria may be behind Crohn's disease

October 19, 2016

People who retain a particular bacterium in their gut after a bout of food poisoning may be at an increased risk of developing Crohn's disease later in life, according to a new study led by researchers at McMaster University.

Neurodevelopmental model of Zika may provide rapid answers

October 19, 2016

A newly published study from researchers working in collaboration with the Regenerative Bioscience Center at the University of Georgia demonstrates fetal death and brain damage in early chick embryos similar to microcephaly—a ...

Scientists uncover new facets of Zika-related birth defects

October 17, 2016

In a study that could one day help eliminate the tragic birth defects caused by Zika virus, scientists from the Florida campus of The Scripps Research Institute (TSRI) have elucidated how the virus attacks the brains of newborns, ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.